Related Experiment Video
Updated: Jan 24, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Sex-Specific Mechanisms in Inflammation and Hypertension
Megan A Sylvester1, Heddwen L Brooks2,3
1Department of Physiology, College of Medicine, University of Arizona, 1656 E. Mabel St/Rm 417, P.O. Box 245218, Tucson, AZ, 85724-5218, USA.
Insights
Hypertension is a pro-inflammatory disease where the immune system plays a key role. Recent research highlights sex-specific mechanisms in immune-mediated hypertension, addressing historical male-only preclinical models.
Area of Science:
- Immunology
- Cardiovascular Disease
- Sex-Based Biology
Background:
- Hypertension is a prevalent chronic disease and a leading cause of cardiovascular and kidney disease.
- Immune system activation is recognized as a critical factor in hypertension development and end-organ damage.
- Historically, preclinical hypertension models predominantly used male animals, limiting understanding of sex-specific disease variations.
Purpose of the Study:
- To critically evaluate recent advancements in sex-specific immune-mediated hypertension.
- To highlight the importance of considering sex as a biological variable in hypertension research.
- To address the lack of sex-specific clinical guidelines and therapeutic targets in hypertension.
Main Methods:
- Review of recent scientific literature on sex differences in immune-mediated hypertension.
- Analysis of studies investigating the role of the immune system in hypertension across sexes.
- Evaluation of preclinical models and their sex-specific relevance.
Main Results:
- Significant progress has been made in understanding sex-specific disease mechanisms since the 2015 NIH policy.
- Immune-mediated pathways in hypertension exhibit distinct characteristics between males and females.
- Emerging research is paving the way for sex-tailored hypertension therapies.
Conclusions:
- Sex-specific approaches are crucial for a comprehensive understanding of immune-mediated hypertension.
- Future research should prioritize sex as a biological variable to develop effective, targeted treatments.
- Addressing sex differences will improve clinical practice and patient outcomes in hypertension management.
Purpose Of Review:
Despite enhanced screening and therapeutic management, hypertension remains the most prevalent chronic disease in the United States and the leading cause of heart disease, chronic kidney disease, and stroke in both men and women. It is widely accepted that hypertension is a pro-inflammatory disease and that the immune system plays a vital role in mediating hypertensive outcomes and end organ damage. Despite known discrepancies in the risk of hypertension development between men and women, preclinical models of immune-mediated hypertension were historically developed solely in male animals, leading to a lack of sex-specific clinical practice guidelines or therapeutic targets.
Recent Findings:
Following the NIH policy on the consideration of sex as a biological variable in 2015, significant advancements have been made into sex-specific disease mechanisms in inflammation and hypertension. This review article serves to critically evaluate recent advancements in the field of sex-specific immune-mediated hypertension.
Related Concept Videos
Inflammation
Sex-linked Disorders
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Primary Motives: Sleep, Sex, and Pain Avoidance
Sleep is a fundamental physiological drive that fosters a state of restfulness crucial for several bodily functions. It facilitates body restoration, the process by which the body repairs, rejuvenates, and maintains itself during sleep, including memory...

